Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine

References

• Eberhardt KB, Rydgren LC, Pettersson H, Wollheim FA. Early rheumatoid arthritis - onset, course, and outcome over 2 years. Rheumatol Int 1990;10:135–42.
   PubMed Web of Science ®Google Scholar
• van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disab-ility in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31: 519–25.
   Google Scholar
• Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumat-oid arthritis. Ann Rheum Dis 1984;43:8–17.
   PubMed Web of Science ®Google Scholar
• Sany J, Kaliski S, Couret M, Cuchacovich M, Daures J. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990;17:1636–41.
   Google Scholar
• Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35: 1263–8.
   Google Scholar
• Kirwan JR. Conceptual issues in scoring radiographic progres-sion in rheumatoid arthritis. J Rheumatol 1999;26:720–5.
   PubMedGoogle Scholar
• Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheum-atoid arthritis. N Engl J Med 1970;283:883–9.
   PubMedGoogle Scholar
• Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of gold salt therapy in rheumat-oid arthritis. Arthritis Rheum 1973;16:353–8.
   PubMed Web of Science ®Google Scholar
• Larsen A, Horton J, Howland C. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis. Clin Rheumatol 1984;3 Suppl 1:97–104.
   Google Scholar
• Buckland-Wright JC. Advances in the radiological assessment of rheumatoid arthritis. Br J Rheumatol 1983;22 Supp1:34–43.
   Google Scholar
• Luukkainen R. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiolo-gical changes and on the optimal time of initiation of therapy. Scand J Rheumatol 1980;34 Supp1:1–56.
   Google Scholar
• Gibson T, Huskisson EC, Wojtulewski JA, Scott PJ, Balme HW, Burry HC, et al. Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehab 1976;15:211–5.
   PubMedGoogle Scholar
• Pullar T, Hunter JA, Capell HA. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987;46:398–402.
   PubMed Web of Science ®Google Scholar
• van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, van de Putte LBA. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up [abstract]. Lancet 1990;335:539.
   PubMed Web of Science ®Google Scholar
• Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, et al. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double-blind, placebo-controlled study. J Rheumatol 1988;15: 1747–54.
   Google Scholar
• Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J. A double-blind randomized parallel trial of intra-muscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 1991;18:328–33.
   PubMedGoogle Scholar
• Lopez-Mendez A, Daniel WW, Reading JC, Ward JR, Alarcon GS. Radiographic assessment of disease progression in rheum-atoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364–9.
   Google Scholar
• Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Arthritis Rheum 1993;36:613–9.
   PubMed Web of Science ®Google Scholar
• Forre O, Norwegian Arthritis Study Group. Radiologic evid-ence of disease modification in rheumatoid arthritis patients treated with cyclosporin. Results of a 48-week multicenter study comparing low-dose cyclosporin with placebo. Arthritis Rheum 1994;37: 1506–12.
   Google Scholar
• Pasero G, Priolo F, Marubini E, Fantini F, Ferraccioli G, Magaro M, et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006–15.
   PubMed Web of Science ®Google Scholar
• Boers M, Verhoeven AC, Markusse HM, van de Laar MAF, Westhovens R, van Denderen JC, et al. Randomised compar-ison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309–18.
   Google Scholar
• Kremer JM. Methotrexate and radiographic disease progres-sion in patients with rheumatoid arthritis. J Rheumatol 1999;26:241–3.
   PubMedGoogle Scholar
• Alarcon GS, Lopez-Mendez A, Walter J, Boerbooms AMT, Russell AS, Furst DE, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate dis-ease-modifying antirheumatic drug-treated rheumatoid arth-ritis patients: a meta-analysis. J Rheumatol 1992;19:1873.
   Google Scholar
• Rau R, Herborn G, Menninger H, Sangha 0. Progression in early erosive rheumatoid arthritis: 12-month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998;37: 1220–6.
   Google Scholar
• Maravic M, Bologna C, Daures J-P, Jorgensen C, Combe B, Sany J. Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol 1999;26:262–7.
   Google Scholar
• Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:577–84.
   PubMed Web of Science ®Google Scholar
• Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142–6.
   PubMed Web of Science ®Google Scholar
• Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 1993;14:381–94.
   Google Scholar
• Rückemann K, Fairbanks L, Carrey E, Hawrylowiez C, Richards D, Kirschbaum B, et al. Leflunomide inhibits pyrimi-dine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 1998;273:21682–91.
   Google Scholar
• Bartlett RR, Popovic S, Raiss RX. Development of autoim-munity in MRL/lpr mice and the effects of drugs on this murine disease. Scand J Rheumatol 1988;75:290–9.
   Google Scholar
• Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Loew-Friedrich I, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumat-oid arthritis: a double-blind, randomised, multicentre trial. Lancet 1999;353:259–66.
   Google Scholar
• Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate. Arch Intern Med 1999;159:2542–50.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arth-ritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheum-atoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481–91.
   Google Scholar
• Larsen A. Radiographic evaluation of rheumatoid arthritis in therapeutic trials. In: Paulus HE, Ehrlich GE, Lindenlaub E, eds. Controversies in the clinical evaluation of analgesic - anti-inflammatory - antirheumatic drugs. New York: F.K. Schattauer Verlag; 1980:323–38.
   Google Scholar
• Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology prelim-inary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727–35.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
   PubMed Web of Science ®Google Scholar
• Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis. Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arth-ritis. Arthritis Rheum 2000;43:495–505.
   Google Scholar
• Paulus HE. Heterogeneity in rheumatoid arthritis radiographic trials. Issues to consider in a metaanalysis. J Rheumatol 2000;27:249–50.
   Google Scholar
• Sharp JT. An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis. J Rheumatol 2000;27:254–60.
   PubMedGoogle Scholar
• Box SA, Pullar T. Sulphasalazine in the treatment of rheumat-oid arthritis. Br J Rheumatol 1997;36:382–6.
   PubMedGoogle Scholar
• Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353:1568–73.
   Google Scholar
• Mottonen TT. Prediction of erosiveness and rate of develop-ment of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648–53.
   PubMed Web of Science ®Google Scholar
• Larsen A, Thoen J. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 1987;16:395–401.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis. A 19-year study of radiographic progres-sion. Arthritis Rheum 1998;41:1571–82.
   PubMedGoogle Scholar
• Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123–9.
   PubMed Web of Science ®Google Scholar
• Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which con-trols the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44–9.
   PubMedGoogle Scholar
• Coste J, Spira A, Clerc D, Paolaggi JB. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited. J Rheumatol 1997;24:28–34.
   PubMedGoogle Scholar
• Graudal N, Tarp U, Junk AG, Galloe AM, Garred P, Milman N, et al. Inflammatory patterns in rheumatoid arthritis estim-ated by the number of swollen and tender joints, the erythro-cyte sedimentation rate, and hemoglobin: long-term course and association to radiographic progression. J Rheumatol 2000;27:47–57.
   PubMed Web of Science ®Google Scholar
• Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326–35.
   PubMed Web of Science ®Google Scholar
• Kuper IH, van Leeuwen MA, van Riel PLCM, Sluiter WJ, Houtman NM, Cats HA, et al. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease. J Rheumatol 1999;26:268–76.
   PubMedGoogle Scholar
• Wassenberg S, Rau R. Problems in evaluating radiographic findings in rheumatoid arthritis using different methods of radiographic scoring: examples of difficult cases and a study design to develop an improved scoring method. J Rheumatol 1995;22:1990–7.
   PubMedGoogle Scholar
• van der Heijde D, Boonen A, Boers M, Kostense P, van der LS. Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology 1999;38:1213–20.
   PubMed Web of Science ®Google Scholar
• Menninger H, Meixner C, Sondgen W. Progression and repair in radiographs of hands and forefeet in early rheumatoid arthritis. J Rheumatol 1995;22:1048–54.
   Google Scholar
• Rau R, Herborn G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1995;22:1976–82.
   PubMed Web of Science ®Google Scholar